Nasopharyngeal carcinoma is closely associated with Epstein-Barr virus (EBV) infection. The EBV-encoded LMP1 has cell transformation property. It suppresses cellular senescence and enhances cell survival in various cell types. Many of the downstream events of LMP1 expression are mediated through its ability to activate NFjB. In this study, we report a novel function of LMP1 to induce Id1 expression in nasopharyngeal epithelial cells (NP69) and human embryonal kidney cells (HEK293). The Id1 is a basic helix-loop-helix (bHLH) protein and a negative transcriptional regulator of p16 INK4a . Expression of Id1 facilitates cellular immortalization and stimulates cell proliferation. With the combination of both specific chemical inhibitors and genetic inhibitors of cell signaling, we showed that induction of Id1 by LMP1 was dependent on its NF-jB activation domain at the carboxy-terminal region, CTAR1 and CTAR2. Induction of Id1 by LMP1 may facilitate clonal expansion of premalignant nasopharyngeal epithelial cells infected with EBV and may promote their malignant transformation. Oncogene (2004 Oncogene ( ) 23, 4488-4494. doi:10.1038 
.1207580 Published online 5 April 2004
Keywords: Epstein-Barr virus; nasopharyngeal carcinoma; LMP1; Id1; nuclear factor kB Nasopharyngeal carcinoma (NPC) is a common cancer among Southern Chinese. The incidence rate of NPC in Hong Kong is 25 times higher than other parts of the world (Jeannel et al., 1999) . NPC is characterized by a high incidence of lymph node metastasis (Sham et al., 1990) and is closely associated with Epstein-Barr virus (EBV) infection (Raab-Traub, 2002) . The EBV-encoded latent membrane protein-1 (LMP1) is essential for EBVinduced immortalization of B lymphocyte (Kaye et al., 1993) Expression of LMP1 transforms Rat-1 fibroblasts (Wang et al., 1985) and induces various phenotypic changes in epithelial cells (Dawson et al., 1990) including loss of contact inhibition, anchorage-independent growth in soft agar and the ability to grow in reduced serum concentrations. LMP1 expression is common in EBV-positive NPC and may play a role in its development (Fahraeus et al., 1988 ; reviewed by Tsao et al., 2002a) . LMP1 is an integral membrane protein consisting of a short N-terminal cytoplasmic domain, a six-transmembrane spanning domain and a 200-residuelong carboxy-terminal (C-terminal) cytoplasmic domain (reviewed by Eliopoulos and Young, 2001) . Aggregation or oligomerization of LMP1 in the membrane is essential for the activation of cell signaling. LMP1 functions as a constitutively active tumor necrosis factor receptor (TNFR), activating a number of signaling pathways in a ligand-independent manner (reviewed by Hatzivassiliou and Mosialos, 2002) . Two distinct functional domains have been identified within the Cterminal regions: C-terminal activation regions 1 and 2 (CTAR 1 and CTAR2). CTAR1 (residue 194-231) has been shown to initiate cell proliferation and CTAR2 (residue 351-386) is essential for permanent lymphoblastoid cell lines outgrowth. Several major signaling pathways from the C-terminal regions of LMP1 have been identified including nuclear factor kB (NF-kB); the mitogen-activated protein kinase (MAP kinase) family (extracellular signal-regulated kinases (ERK), p38, cJun N-terminal kinases (JNK)), the Janus-activated kinase (JAK)/signal transducer and activation of transcription (STAT) and recently the phosphatidylinositol 3-kinase (Dawson et al., 2003) .
LMP1 is a potent activator of the NF-kB signaling pathway in cells (Hatzivassiliou and Mosialos, 2002) . NF-kB activation mediates many downstream events of LMP1 expression including upregulation of antiapoptotic gene products (Bcl-2, Bfl-1, A20 and cIAP); proinflammatory cytokines (IL6 and IL8); cell surface antigens (CD40, CD54 and CD95); and angiogenesis factors (VEGF and COX2). Both CTAR1 and CTAR2 domains of LMP1 are responsible for the activation of NF-kB. Suppression of NF-kB activation results in spontaneous apoptosis of EBV-transformed lymphoblastoid cell lines (Cahir-Mcfarland et al., 2000) .
NPC is closely associated with the EBV infection. The EBV infection may facilitate the transformation of premalignant nasopharyngeal epithelial cells into invasive cancer cells (Pathmanathan et al., 1995) . We have previously shown that LMP1 stimulated proliferation and induced anchorage-independent growth of an immortalized nasopharyngeal epithelial cell line (NP69) (Tsao et al., 2002a; Lo et al., 2003) . LMP1-expressing NP69 cells have a longer survival time upon withdrawal of growth factors (Lo et al., 2003) . In this study, we have investigated some of the downstream events mediating the cell proliferation and survival ability of LMP1-expressing NP69 cells. We have previously shown that overexpression of Id1 stimulated proliferation in NPC cells . There are many similarities in the biological properties between LMP1 and Id1, notably in the enhancement of cell survival and suppression of senescence. We hypothesize that Id1 expression may be induced by LMP1 in immortalized nasopharyngeal epithelial cells. Indeed, Western blotting analysis confirmed that the Id1 protein was upregulated by 3-4 folds in the NP69 cells stably expressing LMP1 (NP69 pLNSX LMP1) compared with the parental NP69 cells or NP69 cells infected with the empty vector (NP69 pLNSX) (Figure 1a and b) . A reduction of p16
INK4a expression level was also observed in LMP1-expressing NP69 cells. We have previously reported that Id1 expression in NPC cells downregulated the Rb/p16
INK4a pathway . This is in agreement to our previous study in rodent fibroblasts, which showed that inactivation of the CDK4/p16
INK4a regulatory pathway was a downstream event of LMP1 (Yang et al., 2000) . The p16
INK4a protein regulates cell cycle G1/S entry and is largely responsible for the onset of replicative senescence in human epithelial cells (Ohtani et al., 2001) . Induction of Id1 expression by LMP1 may be involved in the suppression of p16
INK4a expression in the nasopharyngeal epithelial cells. A recent report showed that LMP1 blocks the Figure 1 Induction of Id1 expression by LMP1 in NP69 cells and HEK293 cells. NP69 is an immortalized nasopharyngeal epithelial cell line. It was established by transfection of a SV40T expression plasmid into primary epithelial outgrowth of nonmalignant nasopharyngeal tissue (Tsao et al., 2002b) . NP69 is nontumorigenic in athymic nude mice and retains many differentiated properties of normal nasopharyngeal epithelial cells. The NP69 cells were propagated in the Defined Keratinocyte-SFM supplemented with growth factors (Gibco, Grand Island, NY, USA) and maintained at 371C with 5% CO 2 in air. HEK293 is an immortalized human embryonal kidney cells. It was used in the transient expression of the LMP1. The HEK293 cells were maintained at 371C with 5% CO 2 in the DME medium (Sigma, St Louis, MO, USA) supplemented with 5% FBS. (a) Western blotting analysis of Id1 and p16 in LMP1-stably expressing NP69 (NP69-pLNSX-LMP1) cells. NP69 cells are the original parental cells. Constitutive expression of LMP1 in NP69 cells was achieved by retroviral expression of an NPC-derived LMP1. The construction of the LMP1 expression vectors had been previously described (Yang et al., 2000) . NP69 cells infected with the empty vector, pLNSX, were also established as a negative control. Expression of LMP1 in NP69-pLNSX-LMP1 cells was confirmed. Detailed experimental procedures of the Western blotting have been described previously . The expression of Id1, p16, LMP1 and actin in this experiment and hereafter were detected by their respective primary antibodies: Id1 (C-20, Santa Cruz Biotechnology, Santa Cruz, CA, USA), p16 (N-20, Santa Cruz Biotechnology, Santa Cruz, CA, USA), LMP1 (CS 1-4, DakoCytomation, Glostrup, Denmark or OT22C, Organon Teknika, Boxtel, the Netherlands) and actin (C-11, Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at room temperature. The secondary antibody used was 1 : 3000 dilution of horseradish peroxidase-linked secondary antibodies (Cell Signaling Technology, Beverly, MA, USA), and the proteins bound by the antibodies were detected by the chemiluminescence reagent ECL Plus (Amersham, Buckinghamshire, UK). (b) The levels of Id1 expression in cells were quantitated by a scanning densitometer. Expression of Id1 was normalized against the actin level. Control expression of Id1 in NP69 cells was set as 1. (c) Induction of Id1 expression by transiently expression of 2117-LMP1 in HEK293 cells incubated in the medium with 1% FBS. Genomic sequence of the prevalent variant of LMP1 (2117-LMP1) in NPC tumor in Hong Kong was PCR amplified and cloned into the EcoRI sites of pcDNA3 vector (Invitrogen, Carlsbad, CA, USA). The entire LMP1 sequence after cloning was confirmed to be inframe by DNA sequencing. The expression of LMP1 after transfection was examined by Western blotting. The efficiencies of both LMP1 expression vectors in activating cell signaling were also confirmed by the luciferase reporter assay for JNK (data not shown) and NF-kB activation. At 24 h before transfection, the HEK293 cells were plated onto a six-well plate with 3 Â 10 4 cells per well. The FuGENE 6 Transfection Reagent (Roche, Indianapolis, IN, USA) was used for transient transfections according to the manufacturer's protocol. Amounts of 1 mg each of pcDNA3 and pcDNA3 2117-LMP1 were transiently transfected in HEK293 cells. After transfection, HEK293 cells were incubated in the DME medium HEPES Modification (Sigma, St Louis, MO, USA) for 48 h with 1% dialysed FBS unless otherwise stated and analysed for INK4a pathway in human fibroblasts through the CRM1-dependent nuclear export of Ets2 (Ohtani et al., 2003) . Ets2 is an important transcription factor for p16
INK4a gene expression. Nuclear export of Ets2 may reduce the expression of p16
INK4a in cells. In that study, downregulation of p16
INK4a by LMP1 via nuclear export of Ets2 was, however, not observed in a human osteosarcoma cell line EH1, suggesting that multiple regulatory mechanisms are involved in the LMP1-induced blockage of p16 INK4a /Rb pathway. We then investigated if transient expression of LMP1 could also induce Id1 expression. Owing to the low transfection efficiency of NP69 cells (around 5%, data not shown), we used the human embryonal kidney HEK293 cells as recipient cells to achieve a higher transfection efficiency of LMP1 cloned in pcDNA expression vector (Invitrogen). The HEK293 cells have been used extensively in the study of LMP1 signaling. Using a GFP expression vector (Clontech) as a transfection marker, we were able to achieve over 80% efficiency of transfection in HEK293 cells (data not shown). Upregulation of Id1 expression after transfection with the LMP1-expressing plasmid was consistently observed in HEK293 cells (Figure 1c and d) . The experiments have been repeated several times to confirm the ability of LMP1 to induce Id1 expression in HEK293 cells.
We then investigated the possible signaling mechanism involved in the induction of Id1 expression by LMP1 using specific cell signaling inhibitors. A panel of chemical inhibitors of cell signaling was used to examine their effects on the Id1 expression in NP69 cells constitutively expressing LMP1. The duration of treatment and concentration of these chemical inhibitors had been previously optimized. The expression of Id1 was effectively inhibited by BAY 11-7085, which could inhibit NF-kB activation (Figure 2a and b) but not by PD098059 and SP600125, inhibitors of MAPkinase and SAPkinase respectively (Figure 2c and d) . On the other hand, potential transcription factor binding sites in the 5 0 region of human Id1 sequence were searched with MatInspector 2.2. based on the TRANSFAC 4.0 transcription factor database (Quandt et al., 1995) . The human Id1 promoter sequence (GenBank Accession Number U57645) (Nehlin et al., 1997) upstream of the TATA box (position À130) was used as the input. The search was limited to the vertebrate transcription factor binding sites, and only those sequences that scored equal or higher than the matrix similarity threshold (0.85) and core similarity threshold (0.75) in the output were treated as the potential binding sites. Two potential NF-kB binding sites (Zabel et al., 1991) were found in the human Id1 promoter at position À1110 and -1947. The involvement of NF-kB activation in the expression of Id1 was further confirmed by cotransfecting the genetic inhibitor of NF-kB, IkB (S32A/S36A), with LMP1 expression vector into HEK293 cells. Cotransfection of IkB (S32A/S36A) mutant, which specifically inhibits activation of NF-kB, suppressed Id1 expression induced by LMP1 (Figure 2e ). Suppression of Id1 expression was not observed in cotransfection experiments of LMP1 with dominant-negative mutants of MAP kinase (pcDNA3.1c XP-MEK1) and SAPkinase (pEBG SEK (KR)). On the other hand, activation of NF-kB by the IKKa expression in turn upregulated the expression of Id1 in HEK293 cells (Figure 2f ). These observations suggest that activation of NF-kB is the major signaling event mediating induction of Id1 expression by LMP1.
NF-kB activation is a major cellular signaling pathway of LMP1, which mediates many downstream events of LMP1. The CTAR1 and CTAR2 are the major domains of LMP1 involved in NF-kB activation . We next examined their involvement in the induction of Id1 expression by transfecting the wild-type LMP1 and mutant LMP1 deficient in CTAR1 and/or CTAR2 expression into HEK293 cells and examined for their ability to induce the Id1 expression. The LMP1 mutants used were pSG5_B95.8-LMP1 AxAxA (deficient at CTAR1 region), pSG5_B95.8-LMP1 378 STOP (deficient in CTAR2 region) and pSG5_B95.8-LMP1 AxAxA/378 STOP (deficient in both CTAR1 and CTAR2 regions). Their intracellular signaling abilities have been characterized in a previous study (Eliopoulos et al., 1999) . LMP1 mutants with deficiency in either CTAR1 or CTAR2 regions were still capable of inducing Id1 expression. However, LMP1 mutants deficient in both CTAR1 and CTAR2 (Figure 3a and b) failed to induce Id1 expression. These results indicated that deletion of both regions were required to abolish the LMP1-mediated Id1 expression and was concordant with previous studies that both CTAR1 and CTAR2 were involved in activation of NF-kB (reviewed by Eliopoulos and Young, 2001) .
Variations in LMP1 sequences are common in EBVassociated diseases. LMP1 natural sequence variants differ in their potential to activate cellular signaling pathways (Fielding et al., 2001) . We then compared the ability of two LMP1 variants, 2117-LMP1 and B95.8-LMP1, to induce the Id1 expression and activate NF-kB signaling. The 2117-LMP1 is the prevalent LMP1 variant isolated from NPC of Hong Kong Chinese (Cheung et al., 1998 ; GenBank Accession Number AY519199). It carries a 30 bp deletion in the C-terminal and has multiple substitutions at various codons in the transmembrane domain and signaling domains of Cterminal. The B95.8-LMP1 (GenBank Accession Number X01995) is the prototypic LMP1 isolated from a case of infectious mononucleosis. Both the genomic 2117-LMP1 and B95.8-LMP1 were cloned into identical expression vector, pcDNA3. The sequences of both LMP1 expression vectors had been determined to ensure the correct reading frame in both expression vectors (data not shown). The 2117-LMP1 was more potent than the B95-8 LMP1 to activate the Id1 expression. The enhanced activity of 2117-LMP1 to activate the Id1 expression was closely related to its activity of NF-kB activation. The optimal dose of LMP1 plasmid used in the activation of Id1 was correlated with the optimal dose in the activation of NF-kB detected by a luciferase reporter system and the phosphorylation status of IkBa (Beg et al., 1992) , MAPkinase (pcDNA3.1c XP-MEK1) (Cowley et al., 1994) and SAPkinase (pEBG SEK (KR)) (Sanchez et al., 1994) . (Figure 4) . The lowered ability of LMP1 to induce the Id1 expression at higher doses (1.5 mg of plasmid) may be related to the cytotoxicity of LMP1 expression at high concentrations (Hammerschmidt et al., 1989) . The cytotoxicity of LMP1 at high level can be inferred from the decrease in the expression of b-Gal gene used as a control to normalize the variation in transfection efficiencies among each sample (Table 1 ).
All the above results in this report support the conclusion that induction of Id1 expression by LMP1 is likely to be mediated by the activation of NF-kB. The significance of LMP1 induction in nasopharyngeal epithelial cells is not fully understood at this stage. Id1 has been shown to be upregulated in cells that had overcome replicative senescence and also in cells with enhanced survival in growth factor-deprived environment. Id1 expression could extend the lifespan of human keratinocytes and, in some cases, immortalize them (Alani et al., 1999) . We have also shown that the Id1 expression itself could induce MAPkinase and cell proliferation in prostatic carcinoma cells . Recently, we have also reported that LMP1 expression in an immortalized nasopharyngeal epithelial cell line (NP69) could stimulate an array of genes involved in cell survival (Lo et al., 2003) . LMP1 expression could be detected in the premalignant nasopharyngeal lesions (Pathmanathan et al., 1995) . LMP1-induced Id1 expression may stimulate cell proliferation, enhancing cell survival and escape from cellular senescence, so that may confer selective growth advantage in nasopharyngeal epithelial cells.
The relationship between LMP1 and Id1 expression in NPC is likely to be complex and deserves further study to fully understand its significance. Immunocytochemistry staining of LMP1 in NPC biopsies generally revealed a low and heterogeneous expression level (reviewed in Tsao et al., 2002a) . Multiple cellular pathways are believed to be involved in the activation of Id1 in cancer cells. Overexpression of Id1 is commonly detected in non-EBV-associated malignancies (Sikder et al., 2003) . We postulate that advanced NPC may be less dependent on the Id1 induction by LMP1 as they commonly acquire additional genetic alterations, for example, p16 and RASSF1A inactivation, which facilitate survival of cells and their escape from senescence. LMP1 expression is commonly detected in premalignant lesions of NPC and has been postulated to play a role in transformation of premalignant nasopharyngeal epithelial cells into invasive cancer cells (Pathmanathan et al., 1995) . LMP1 induction of Id1 expression may have a more significant role at the early stage of NPC development. Our findings support a role of LMP1 in the transformation of premalignant epithelial cells into invasive cancer cells at the early stage of NPC development.
In summary, we have identified a novel function of LMP1 in the induction of Id1 expression in human nasopharyngeal epithelial cells through activation of NF-kB, and the CTAR1 and CTAR2 regions of the LMP1 are involved in the induction of Id1. Our study supports a role of LMP1 in cellular immortalization and transformation of premalignant nasopharyngeal epithelial cells at an early stage of carcinogenesis.
Abbreviations NPC, nasopharyngeal carcinoma; EBV, Epstein-Barr virus; LMP1, latent membrane protein 1; Id, inhibition of DNA Figure 3 Effects of the expression of LMP1 with mutations at CTAR1 and CTAR2 regions on the Id1 expression. The prototype LMP1 sequence (B95.8-LMP1) was originated from infectious mononucleosis patients, and the construction and properties of pSG5 B95.8-LMP1 (wt), pSG5 B95.8-LMP1 AxAxA/378 STOP, pSG5 B95.8-LMP1 AxAxA, pSG5 B95.8-LMP1 378 STOP had been previously described (Eliopoulos et al., 1999) . Amounts of 0.1 mg each of the wild type and the mutant B95.8-LMP1 were transfected into HEK293 cells respectively. The pSG5 empty vector was also added to make the total amount of DNA in each transfection as 1 mg. 6 HEK293 cells were cotransfected with NF-kB luciferase reporter (3Enh.kBconA-Luc reporter) and with 0.1, 0.5 and 1.5 mg pcDNA3 2117-LMP1 and pcDNA3 B95.8-LMP1 using a standard calcium phosphate technique previously described (Blake et al., 2001) . The RSV-b-Gal vector was also transfected as control to normalize the transfection efficiency. At 36 h post-transfection, cells were lysed in reporter lysis buffer and subjected to luciferase assay by luminometer. The results represent the means of three independent experiments relative to b-Gal control binding or differentiation; NF-kB, nuclear factor kB; IkBa, inhibitor of kB alpha; FBS, fetal bovine serum.
